# US 2024/0389925 A1 · Photoacoustic voltage indicators

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0389925 A1
- Document ID: US20240389925A1
- Status: Published application
- Kind: A1
- Application number: 18/798,164
- Filed: 2024-08-08
- Published: 2024-11-28
- Earliest claimed: 2020-11-23
- Assignees: Arizona Board of Regents on behalf of Arizona State University
- Inventors: Barbara SMITH; Christopher MIRANDA
- Web page: https://patentgrep.com/patent/US20240389925A1

## CPC

- A61B 5/4064: {Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369)}
- A61B 5/0095: {by applying light and detecting acoustic waves, i.e. photoacoustic measurements}
- G01N 15/1023: {Microstructural devices for non-optical measurement}
- G01N 21/1702: {with opto-acoustic detection, e.g. for gases or analysing solids}
- G01N 29/2418: {using optoacoustic interaction with the material, e.g. laser radiation, photoacoustics (photoacoustic cells G01N21/1702; measuring characteristics of vibrations by using radiation-sensitive means G01H9/00; acousto-optical conversion techniques for short-range imaging G01S15/8965; sound-producing devices using laser bundle G10K15/046)}
- G01N 15/01: specially adapted for biological cells, e.g. blood cells (investigating sedimentation of particle suspensions in blood G01N15/05)
- G01N 15/1031: by measuring electrical or magnetic effects
- G01N 2015/1006: {for cytology}
- G01N 2021/1706: {in solids}
- G01N 2291/015: Attenuation, scattering
- G01N 2291/02466: Biological material, e.g. blood
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A system for measuring a membrane potential is disclosed. The system comprises a photoacoustic probe including a laser and an ultrasound transducer. The laser is configured to emit a light signal at one or more wavelengths to a neuronal cell. The neuronal cell may comprise a voltage-sensitive protein configured to absorb the light signal in a voltage-dependent manner. The ultrasound transducer is configured to receive a photoacoustic signal from the voltage-sensitive protein in response to absorbing the light signal. The system further comprises a processor configured to receive the photoacoustic signal from the ultrasound transducer and calculate a membrane potential of the neuron based on the photoacoustic signal. Methods of measuring a membrane potential and biomaterials related to the voltage-sensitive protein are also disclosed herein.

## Claims

### Claim at position 1

1-23. (canceled)

### Claim 24

An engineered biomaterial comprising:
one or more neuronal cells, wherein each neuronal cell expresses a voltage-sensitive protein configured to absorb light at one or more wavelengths,
wherein at least one light absorption characteristic of the voltage-sensitive protein is configured to shift based on a membrane potential of the neuronal cell.

### Claim 25 (depends on 24)

The engineered biomaterial of claim 24, wherein the voltage-sensitive protein comprises a transmembrane protein.

### Claim 26 (depends on 25)

The engineered biomaterial of claim 25, wherein the transmembrane protein comprises a rhodopsin.

### Claim 27 (depends on 24)

The engineered biomaterial of claim 24, wherein the at least one light absorption characteristic comprises an absorption coefficient of the voltage-sensitive protein,
wherein the absorption coefficient is configured to shift based on the membrane potential sensed by the voltage-sensitive protein.

### Claim 28 (depends on 24)

The engineered biomaterial of claim 24, wherein the at least one light absorption characteristic comprises a peak absorption wavelength of the voltage-sensitive protein,
wherein the peak absorption wavelength is configured to shift based on the membrane potential sensed by the voltage-sensitive protein.

### Claim 29 (depends on 24)

The engineered biomaterial of claim 24, wherein each neuronal cell comprises a gene encoding the voltage-sensitive protein delivered to the neuronal cell by a vector.

### Claim 30 (depends on 24)

The engineered biomaterial of claim 24, wherein the voltage-sensitive protein is configured to absorb light at the one or more wavelengths in a voltage-dependent manner with sensitivity to changes in the membrane potential across a voltage range of about −70 mV to about 30 mV.

### Claim 31 (depends on 24)

The engineered biomaterial of claim 24, wherein the voltage-sensitive protein has an extinction coefficient between about 102 M−1 cm−1 to about 104 M−1 cm−1.

### Claim 32 (depends on 24)

The engineered biomaterial of claim 24, wherein the voltage-sensitive protein is configured to absorb light at the one or more wavelengths in the voltage-dependent manner with a voltage response time of less than about 3 ms.

### Claim 33 (depends on 24)

The engineered biomaterial of claim 24, wherein the voltage-sensitive protein is configured to absorb light at the one or more wavelengths in the voltage-dependent manner with a voltage response time of less than about 1 ms.

### Claim 34

An engineered biomaterial comprising:
one or more neuronal cells, wherein each neuronal cell expresses a voltage-sensitive protein having a light absorption characteristic;
wherein the voltage-sensitive protein is configured to emit a photoacoustic signal upon absorption of a light signal based on a shift in the light absorption characteristic;
wherein the photoacoustic signal is indicative of the transmembrane potential of the one or more neuronal cells.

### Claim 35 (depends on 34)

The engineered biomaterial of claim 34, wherein the voltage-sensitive protein comprises a transmembrane protein.

### Claim 36 (depends on 35)

The engineered biomaterial of claim 35, wherein the transmembrane protein comprises a rhodopsin.

### Claim 37 (depends on 34)

The engineered biomaterial of claim 34, wherein the at least one light absorption characteristic comprises an absorption coefficient of the voltage-sensitive protein,
wherein the absorption coefficient is configured to shift based on the membrane potential sensed by the voltage-sensitive protein.

### Claim 38 (depends on 34)

The engineered biomaterial of claim 34, wherein the at least one light absorption characteristic comprises a peak absorption wavelength of the voltage-sensitive protein,
wherein the peak absorption wavelength is configured to shift based on the membrane potential sensed by the voltage-sensitive protein.

### Claim 39 (depends on 34)

The engineered biomaterial of claim 34, wherein each neuronal cell comprises a gene encoding the voltage-sensitive protein delivered to the neuronal cell by a vector.

### Claim 40 (depends on 34)

The engineered biomaterial of claim 34, wherein the voltage-sensitive protein is configured to absorb light at the one or more wavelengths in a voltage-dependent manner with sensitivity to changes in the membrane potential across a voltage range of about −70 mV to about 30 mV.

### Claim 41 (depends on 34)

The engineered biomaterial of claim 34, wherein the voltage-sensitive protein has an extinction coefficient between about 102 M−1 cm−1 to about 104 M−1 cm−1.

### Claim 42 (depends on 34)

The engineered biomaterial of claim 34, wherein the voltage-sensitive protein is configured to absorb light at the one or more wavelengths in the voltage-dependent manner with a voltage response time of less than about 3 ms.

### Claim 43 (depends on 34)

The engineered biomaterial of claim 34, wherein the voltage-sensitive protein is configured to absorb light at the one or more wavelengths in the voltage-dependent manner with a voltage response time of less than about 1 ms.
